IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
Managing the Diagnostic and Therapeutic Challenges of Irritable Bowel Syndrome
Abstract: The management of patients with irritable bowel syndrome (IBS) remains a common clinical challenge for health care providers. IBS is a prevalent disorder that encompasses […]
From Recent Issues
Feature
Managing the Diagnostic and Therapeutic Challenges of Irritable Bowel Syndrome
Abstract: The management of patients with irritable bowel syndrome (IBS) remains a common clinical challenge for health care providers. IBS is a prevalent disorder that encompasses […]
Feature
Update on Pregnancy in Inflammatory Bowel Disease
Abstract: Ongoing clinical and population health research continues to inform evidence-based management of patients with inflammatory bowel disease during pregnancy. Advances in noninvasive tools for disease […]
Feature
Impact of Menopause and Clinical Considerations in Patients With Inflammatory Bowel Disease
Abstract: Menopause is marked by a natural decline in estrogen and progesterone that alters gut barrier integrity, immune regulation, and systemic inflammation. In women with inflammatory […]
Supplements
QOL-Guided Decision-Making to Switch Mechanism of Action in IBS-C: Applying JUST ASK Study Principles in Clinical Practice
About the Patient JS, a 38-year-old man, presented with long-standing complaints of persistent bloating, abdominal distension, constipation, incomplete evacuation, and reduced quality of life. He had […]
Connecting the Dots Between Theory and Practice: Speaking With Your Patients About IBS-C Management
About the Patient MB is a 32-year-old woman with symptoms of constipation dating back to college. She notes that these symptoms have worsened over the past […]
Highlights in MASH From the American College of Gastroenterology 2025 Annual Scientific Meeting
A Review of Selected Presentations From the ACG 2025 Annual Scientific Meeting October 24-29, 2025 • Phoenix, Arizona Treatment With Resmetirom for Up to 2 Years […]